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HDAC6Alzheimer's disease is the most common progressive neurodegenerative disorder characterized by the abnor-
mal deposition of amyloid plaques, likely as a consequence of an incorrect processing of the amyloid-β pre-
cursor protein (AβPP). Dysfunctions in both the ubiquitin–proteasome system and autophagy have also been
observed. Recently, an extensive cross-talk between these two degradation pathways has emerged, but the
exact implicated processes are yet to be clariﬁed. In this work, we gained insight into such interplay by ana-
lyzing human SH-SY5Y neuroblastoma cells stably transfected either with wild-type AβPP gene or 717
valine-to-glycine AβPP-mutated gene. The over-expression of the AβPP mutant isoform correlates with an in-
crease in oxidative stress and a remodeled pattern of protein degradation, with both marked inhibition of
proteasome activities and impairment in the autophagic ﬂux. To compensate for this altered scenario, cells
try to promote the autophagy activation in a HDAC6-dependent manner. The treatment with amyloid-β42
oligomers further compromises proteasome activity and also contributes to the inhibition of cathepsin-mediated
proteolysis, ﬁnally favoring the neuronal degeneration and suggesting the existence of an Aβ42 threshold level
beyond which proteasome-dependent proteolysis becomes deﬁnitely dysfunctional.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative dis-
order pathologically characterized by the neuroﬁbrillary tangles of
hyperphosphorylated tau protein, amyloid-β plaques and loss of neu-
rons and synapses in speciﬁc brain regions [1]. These plaques are formed
mostly by 40 and 42 amino acid long peptides (Aβ40 and Aβ42, respec-
tively), derived from the proteolytic cleavages of the amyloid precursor
protein (AβPP) [1]. Considering the centrality of AβPP in the generation
of the amyloid peptides, it is clear that alterations in the AβPP pathway
may directly contribute to the disease pathogenesis [2]. Previous studies
suggested a role for the proteasome and lysosomes in AβPP processing,
indicating that an impairment in their activity can favor the onset of
the disorder [3,4]. The 26S proteasome is a large, barrel shaped protease
complex in charge of the removal of intracellular misfolded, oxidized or
aggregated proteins in the presence of ubiquitin (Ub) and ATP. The cata-
lytic core of this structure is the 20S proteasome, possessing four wellAβ40, amyloid-β (1–40); Aβ42,
; HDAC6, histone deacetylase
ylglutamyl-peptide hydrolyzing;
acids preferring; CM-H2DCFDA,
acetate acetyl ester
arini).
rights reserved.characterized proteolytic activities [5]. Numerous data demonstrated
that AD and other neurodegenerations are characterized by an impaired
functionality of the Ub–proteasome system (UPS) and that amyloid ag-
gregates are able to inhibit such complex [6–8]. Furthermore, it was
also reported that proteasome inhibition altered AβPP processing, mod-
ulating Aβ production [3,9]. Differently, lysosomes are responsible for
the degradation and recycling of intracellular components through
autophagic pathways [10]. Autophagy is crucial for both neuronal
homeostasis and survival during nutrient starvation, hence damages
in the autophagic ﬂux promote severe cellular alterations with the
accumulation of abnormal proteins and/or damaged organelles [11].
The lysosomal enzymes cathepsin B and cathepsin L can interfere with
AβPP processing, thus altering the Aβ release [12]. The in vivo treat-
mentwith a cathepsin B inhibitor of London APPmice, an ADmodel ex-
pressing human APP containing thewt β-secretase site andmutation at
the γ-secretase, improved memory function, reduced amyloid plaque
load, decreased Aβ40 and Aβ42, and reduced β-secretase-cleaved AβPP
C-terminal fragments [13].
An extensive cross-talk between the proteasomal system and lyso-
somal degradation has been documented [14,15], but the exact mecha-
nisms implicated in such cooperation have to be better clariﬁed. On this
regard, the histone deacetylase 6 (HDAC6) deserves attention being not
only dedicated to genomic functions, but also involved in cytoplasmic
pathways. This enzyme includes a Ub-binding domain that associates
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aggresome formation, favoring the transport of ubiquitinated misfolded
proteins through microtubules, and to aggresome clearance [16,17].
HDAC6 regulates Hsp90 functions through reversible acetylation, thus
its inactivation triggers Hsp90 hyperacetylation, with the resulting
loss of chaperone activity [18]. Pandey et al. found that compensato-
ry autophagy was induced in Drosophila melanogaster in a HDAC6-
dependent manner in response to mutations affecting the proteasome,
suggesting that damages to the autophagic pathway might predispose
to neurodegenerative processes [15,19].
Here, we dissected the regulation of the two proteolytic systems
in Alzheimer's disease using human SH-SY5Y neuroblastoma cells
stably transfected with either wild-type AβPP gene (APPwt) or 717
valine-to-glycine AβPP-mutated gene (APPmut) as experimental model.
Our data show that the over-expression of the amyloid precursor protein
correlateswith an increase in oxidative stress andwith a reorganization
of the cellular proteolytic machineries. Additionally, we identify the
HDAC6-increased expression as a cellular attempt to activate compen-
satory autophagy in such altered scenario. The further increase in Aβ42
levels undeniably compromises proteasome activity and contributes to
the inhibition of cathepsins, ﬁnally favoring the neuronal degeneration.
2. Material and methods
2.1. Reagents and chemicals
Substrates for assaying the chymotrypsin-like (ChT-L), trypsin-like
(T-L), peptidylglutamyl-peptide hydrolyzing (PGPH), aminopeptidase N
(AP-N) activities and proteasome inhibitors, Z-Gly-Pro-Phe-Leu-CHO
and lactacystin, were purchased from Sigma-Aldrich S.r.L. (Milano,
Italy). The substrate Z-Gly-Pro-Ala-Phe-Gly-pAB to test the branched-
chain amino acids preferring (BrAAP) activity was a kind gift from
Prof. Orlowski (Department of Pharmacology, Mount Sinai School of
Medicine, New York, USA). Aminopeptidase N (EC 3.4.11.2) for the
coupled assay utilized to detect BrAAP activity [20], was puriﬁed from
pig kidney as reported elsewhere [21]. Cathepsin B and cathepsin L sub-
strates (Z-Arg-Arg-AMC and Z-Phe-Arg-AFC.triﬂuoroacetate) and in-
hibitors (CA074Me and N-(1-Naphthalenylsulfonyl)-Ile-Trp-aldehyde)
were obtained from Sigma-Aldrich S.r.L. (Milano, Italy). Lyophilized
Aβ42 was purchased from Invitrogen and stored as powder at−20 °C
until reconstitution in hexaﬂuoroisopropanol (HFIP). Media and
chemicals used for cell cultures were purchased from Enzo Life Sci-
ences, Inc. NuPAGE® Novex 12% Bis-Tris gels for SDS-PAGE were pur-
chased from Invitrogen (Milano, Italy). Membranes for western
blotting analyses were purchased from Millipore (Milano, Italy). Pro-
teins immobilized on ﬁlms were detected with the enhanced chemilu-
minescence (ECL) system (Amersham Pharmacia Biotech, Milano,
Italy).
2.2. Cell culture and transfections
SH-SY5Y cells were cultured in 1:1 Dulbecco's modiﬁed Eagle's me-
dium and Nutrient Mixture F12 containing 10% fetal bovine serum
(FBS), 2 mM glutamine, 100 units/mL penicillin, and 100 μg/mL strep-
tomycin at 37 °C in a 5% CO2-containing atmosphere. The SH-SY5Y
cell stable transfection with wild type AβPP 751 (APPwt) and AβPP
(Val717Gly) mutations (APPmut), was prepared as follows. Cells, seed-
ed on polylysine-coated 6-well plate at 80% of conﬂuence density, were
transfected with 1 μg/well of pcDNA–APP751 vector or 1 μg/well of
pcDNA–APP751(Val717Gly) mutation vector using Lipofectamine™
2000 reagent (Invitrogen, Milano, Italy). G418 was added at a con-
centration of 800 μg/mL and drug resistant cells were collected
after 2–3 weeks for single cell cloning; transfected cells were diluted,
and seeded in 96-well plates at one cell per well. Wells containing
more than 1 cell were marked and excluded from further investigation.
50% medium in each well was replaced twice a week. After 4–6 weeks,surviving clones reached conﬂuence and were expanded for banking.
Resistant clones were analyzed by western blotting to conﬁrm the AβPP
overexpression. Stable transfected cells expressing either the APPwt or
the APPmut construct were maintained in G418 at a ﬁnal concentration
of 300 μg/mL.
2.3. Preparation of cellular lysates and western blotting
After removing the medium and washing with cold phosphate
buffered saline (PBS), cells were harvested in 4 mL of PBS and
centrifuged at 1600×g for 5 min. The pellet was resuspended in a
lysis buffer (20 mM Tris, pH 7.4, 250 mM sucrose, 1 mM EDTA and
5 mM β-mercaptoethanol) and passed through a 29-gauge needle
at least ten times. Lysates were centrifuged at 12,000×g for 15 min
and the supernatants were stored at −80 °C. Protein concentration
was determinedby themethodof Bradford [22] using bovine serumalbu-
min (BSA) as standard. Cell lysates were then resolved by 12% SDS‐PAGE
and electroblotted onto PVDF membranes. Membranes with transferred
proteinswere incubatedwith primarymonoclonal antibodies and succes-
sively with the speciﬁc peroxidase-conjugated secondary monoclonal
antibodies (Abcam, Cambridge, UK). The immunoblot detection was
performed with an ECL western blotting analysis system. Each gel was
loaded with molecular mass markers, in the range of 6.5 kDa to
205 kDa (SigmaMarker — Wide Molecular Weight Range; Sigma-
Aldrich S.r.l.). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
or α-tubulin was utilized as control for equal protein loading: mem-
branes were stripped and re-probed for GAPDH or α-tubulin using a
monoclonal antibody diluted 1:500 (Santa Cruz Biotech, Heidelberg,
Germany). The bands were quantiﬁed as reported elsewhere [23].
2.4. Detection of autophagic markers
For the immunoﬂuorescence analysis of LC3, cells were serum starved
for 4, 6 and 8 h and ﬁxed in 1:1 (v/v) methanol and acetic acid for 5 min
at−20 °C. After washing with PBS, cells were labeled with the anti-LC3
monoclonal antibody in PBS containing 1% BSA. Fluorescein-conjugated
secondary antibody was used. Cells were stained with Hoechst dye and
then slides were mounted with Moviol and examined using a ﬂuores-
cence microscope. Quantitative analysis was performed by counting the
number of LC3 positive dots in six different ﬁelds/slices. Nearly 20 cells/
ﬁeld were counted. For each sample, at least, three different slices were
evaluated. The state of the autophagic ﬂux was assessed upon 8 h of
serumdeprivation throughwestern blotting assayswith speciﬁc prima-
ry antibodies detecting the levels of autophagy related proteins such as
LC3-II, beclin-1 (both antibodies purchased fromPierce Biotech, Rockford,
USA) and p62 (antibody purchased from Sigma-Aldrich, Milano, Italy)
and the amount of Ub–protein conjugates (monoclonal anti-Ub anti-
body purchased from Santa Cruz Biotechnology, Inc. Heidelberg,
Germany).
2.5. Cell viability
Cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) conversion as previously described
[24]. Brieﬂy, following experimental treatment, cells were washed in
PBS, pH 7.5, and then MTT (ﬁnal concentration 0.5 mg/mL) was added
to the culture medium without FBS and incubated for 2 h at 37 °C. The
mediumwas then removed and replacedwith 100 μL of DMSO. The opti-
cal density was measured at 550 nm in a microtiter plate reader. At least
six cultures were utilized for each time point.
2.6. Quantiﬁcation of protein carbonyls (PC)
Protein carbonyls were determined as described in Prof. Butterﬁeld's
laboratory [25]. Samples were treated following the procedure of the
OxyBlot™ protein oxidation detection kit (Chemicon Millipore, Billerica,
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brane with a dot-blot apparatus (2 μg per dot) in quadruplicate. The
membrane was blocked with a solution of 5% non-fat dried milk in
Tris-buffered saline (TBS) solution and followed by incubation with rab-
bit polyclonal anti-DNPHantibody (1:100) as primary antibody for 1 h at
room temperature. After washing, the membrane was incubated with
HRP-conjugated goat anti-rabbit secondary antibody (1:300) for 1 h at
room temperature. Blots were developed using a chemiluminescence
blotting substrate kit and densitometric analysis was performed using
Scion Image software (Scion Corporation). Data were normalized to
α-tubulin.
2.7. Quantiﬁcation of 3-nitrotyrosine (3-NT)
The 3-NT content was determined immunochemically as previ-
ously described [26]. Brieﬂy, samples were incubated with Laemmli
sample buffer in a 1:2 ratio (0.125 M Trizma base, pH 6.8, 4% SDS,
20% glycerol) for 20 min. Proteins (5 μg) were then blotted in qua-
druplicate onto the nitrocellulose paper using the slot-blot appara-
tus and immunochemical methods were conducted as described
above for protein carbonyls. The rabbit anti-3-NT primary antibody
(1:1000 dilution) (Sigma-Aldrich, Milano, Italy) was incubated
overnight at 4 °C and at room temperature for 3 h. Next, the
HRP-conjugated goat anti-rabbit secondary antibody (1:1500, Dako,
Glostrup, Denmark) was incubated for 2 h at room temperature. Densi-
tometric analysis was performed using Scion Image software. Data
were normalized to α-tubulin.
2.8. Quantiﬁcation of 4-hydroxynonenal (HNE)
Detection of HNE adducts was performed as follows. Samples (5 μg)
were incubated with Laemmli buffer containing 0.125 M Tris base pH
6.8, 4% (v/v) SDS, and 20% (v/v) glycerol in a 1:1 ratio. The resulting
samplewas loaded perwell in the slot blot apparatus containing a nitro-
cellulose membrane under vacuum pressure. The membrane was
blocked with a solution of 5% non-fat dried milk in TBS and incubated
with the anti-HNE polyclonal antibody (1:200 dilution, Alpha Diagnos-
tic, Vinci-Biochem, Vinci, Italy) overnight at 4 °C and 3 h at room tem-
perature. An anti-rabbit IgG alkaline phosphatase secondary antibody
(Dako, Glostrup, Denmark) was diluted 1:1500 in a solution of 5%
non-fat dried milk in TBS and added to the membrane for 2 h at room
temperature. Densitometric analysis was performed using Scion Image
software. Data were normalized to α-tubulin.
2.9. Evaluation of ROS production in mitochondria
Mitochondrial ROS production was analyzed in real time by a
video-rate confocal microscopy-based method. Brieﬂy, cells were plated
in glass wells and re-suspended after 24 h in a physiological buffer
containing the ROS detection reagent (CM-H2CFDA) at theﬁnal concen-
tration of 1 μM. Cells were also loaded with Mitotracker Deep Red 633
FM (100 nM) (Invitrogen, Milan, Italy) for 45 min in 5% CO2 at 37 °C
for mitochondrial localization. CM-DCF ﬂuorescence intensity was se-
lectively recorded in mitochondria. Fluorescence emission intensity
was calculated as the average green level value per pixel and corrected
for background in at least 4 different ﬁelds.
2.10. Aβ aggregates production and cell treatment
The different aggregation states of Aβ42 were obtained following the
Dahlgren et al. protocol [27]withminormodiﬁcations. Brieﬂy, lyophilized
Aβ42 peptides were dissolved in HFIP at a concentration of 1 mM. HFIP
was removed by vacuum evaporation and the ﬁlmwas stored as aliquots
in sterilemicrocentrifuge tubes at−80 °C until used. Immediately prior
to the use, theﬁlmwas solubilized in DMSO to a concentration of 5 mM.
For oligomeric conditions, Ham's F12 was added to bring the peptide toa ﬁnal concentration of 100 μM and incubated at 4 °C for 6 days. For
unaggregated conditions, the peptide was dissolved in DMSO and di-
rectly diluted into cell culture media. Oligomerization was monitored
by western blotting using the mouse monoclonal antibody 6E10
(Santa Cruz Biotechnology, Inc. Heidelberg, Germany), speciﬁc for the
residues 1–17 of Aβ, as previously described [28]. Then, cells were
grown in 100-mm tissue culture dishes at an initial concentration of
2×106 cells/dish and were exposed to 1 μM of soluble and oligomeric
forms of Aβ42 for 6 and 24 h. Controls were performed in the presence
of DMSO for each time point.
2.11. Measurements of proteasome activities in cell lysates
Proteasomepeptidase activities in cell lysateswere determinedwith
ﬂuorogenic peptides: Suc-Leu-Leu-Val-Tyr-AMC was used for ChT-L ac-
tivity, Z-Leu-Ser-Thr-Arg-AMC for T-L activity, Z-Leu-Leu-Glu-AMC for
PGPH activity, and Z-Gly-Pro-Ala-Phe-Gly-pAB for BrAAP activity [29].
The incubation mixture contained 1 μg of cell lysates, the appropriate
substrate and 50 mM Tris–HCl pH 8.0, up to a ﬁnal volume of 100 μL. In-
cubationwas performed at 37 °C, and after 60 min theﬂuorescence of the
hydrolyzed 7-amino-4-methyl-coumarin (AMC) and 4-aminobenzoic
acid (pAB) was detected (AMC, λexc=365 nm, λem=449 nm; pAB,
λexc=304 nm, λem=664 nm) on a SpectraMax Gemini XPS microplate
reader. The 26S proteasome ChT-L activity was tested using Suc-Leu-
Leu-Val-Tyr-AMC as substrate and 50 mM Tris–HCl pH 8.0 buffer
containing 10 mM MgCl2, 1 mM dithiothreitol, and 2 mM ATP. BrAAP
activity was determined in a coupled test in the presence of aminopep-
tidase N. The effective 20S proteasome contribution to short peptide
cleavagewas evaluatedwith control experiments performed using spe-
ciﬁc proteasome inhibitors, Z-Gly-Pro-Phe-Leu-CHO and lactacystin
(5 μM in the reaction mixture). The ﬂuorescence values of lysates were
subtracted of the values of control assays in the presence of the two
inhibitors.
2.12. Measurements of cathepsins activities in cell lysates
Cathepsin B and L proteolytic activities were measured following
the protocol described by Tchoupè et al. [30] using the ﬂuorogenic
peptides Z-Arg-Arg-AMC and Z-Phe-Arg-AFC. triﬂuoroacetate, respec-
tively, at a ﬁnal concentration of 50 μM. The mixture, containing 1 μg
of protein lysate, was incubated in 100 mM phosphate buffer pH 6.0,
1 mM EDTA and 2 mM dithiothreitol for 1 h at 30 °C. The ﬂuorescence
of the hydrolyzed 7-amino-4-methyl-coumarin (AMC, λexc=365 nm,
λem=449 nm) and 7-amino-4-triﬂuoromethylcoumarin (AFC, λexc=
400 nm, λem=505 nm) was detected on a SpectraMax Gemini XPS
microplate reader. The effective cathepsins contribution to the proteolysis
was evaluated through control experiments performed using the speciﬁc
inhibitors CA074Me and N-(1-naphthalenylsulfonyl)-Ile-Trp-aldehyde)
for cathepsins B and L, respectively. Fluorescence values obtained by an-
alyzing the lysates were then subtracted of the values of control assays
in the presence of the two inhibitors.
2.13. Hsp90 immunoprecipitation
Hsp90 immunoprecipitation was conducted on cell lysates using
an anti-Hsp90 antibody coupled with protein A-Sepharose CL-4B
(Sigma-Aldrich, St Louis, MO, USA). The immunoprecipitation was
carried out as previously described [31]. After immunoprecipitation,
each pellet was resuspended in 50 μL Laemmli sample buffer, heated at
95 °C for 5 min, centrifuged for 30 s at 12,000×g, and pooled superna-
tants were used for western blotting analyses with an anti-acetylated ly-
sine antibody (Santa Cruz Biotech., Heidelberg, Germany). Immunoblot
detectionwith an anti-Hsp90-antibody (Santa Cruz Biotech., Heidelberg,
Germany) was performed to verify the efﬁciency of the immunoprecip-
itation procedure and to control the equal protein loading.
Fig. 1. AβPP levels in APPwt and APPmut cells. A) Representative western blotting of total
extracts from SH-SY5Y neuroblastoma cells over-expressing wild-type AβPP gene (APPwt)
or mutated AβPP gene (APPmut). Analysis was carried out using the monoclonal mouse
6E10 antibody. α-Tubulin was used as control for equal protein loading. B) Panel B shows
the densitometric analysis of the AβPP amount performed in three different culture prepa-
rations of SH-SY5Y, APPwt and APPmut cell lines. Data points marked with an asterisk are
statistically signiﬁcant compared to control SH-SY5Y cells (*pb0.0002).
Table 1
Oxidative proﬁle in SH-SY5Y overexpressing APPwt and APPmut. Oxidative stress was
evaluated as the expression of HNE-Michael adducts, 3-nitro-tyrosine (3-NT) and protein
carbonyl (PC) levels, as well as the amount of ROS inside the mitochondria.
HNE-Michael
adducts
3-NT PC Mitochondrial
ROS
SH-SY5Y 1.2±0.18 0.62±0.16 0.85±0.17 187.00±38.01
APPwt 2.90±0.75 1.61±0.18 1.95±0.56 98.86±29.67
APPmut 4.30±0.95⁎ 2.78±0.08⁎⁎ 2.80±0.38⁎⁎⁎ 453.33±32.51§
⁎pb0.001 APPmut vs SH-SY5Y; ⁎⁎pb0.005 APPmut vs SH-SY5Y; ⁎⁎⁎pb0.005 APPmut
vs SH-SY5Y; §pb0.005 APPmut vs SH-SY5Y.
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For immunocytochemistry, cells were cultured in a Chamber Slide
system, and after 24 h of incubation with both Aβ42 forms, the mono-
layers were rapidly ﬁxed in a 50:50 mixture of methanol and acetone
for 5 min. For triple-labeling immunocytochemistry, monolayers were
incubated ﬁrst with the anti-20S core antibody (1:50, Enzo Life sciences,
UK); with the anti-cathepsin B antibody (1:100, Santa Cruz Biotech.,
Heidelberg, Germany), and the anti-Aβ42 antibody (1:50, JBC1766774,
Millipore, Oak Drive, Temecula, CA), and then with biotin-labeled goat
anti-rabbit (1:200, Jackson ImmunoResearch, West Grove, PA) second-
ary antibody. The binding of the antibodywas detectedwith the Elite kit
(Vector Laboratories), and the immunoreaction was developed using
three different chromogens; violet (VIP, Vector, Burlingame UK) for
cathepsin-B, grayish-black (diaminobenzidine hydrochloride developed
with nickel addition, Vector) for anti-20S proteasome, and brown (DAB,
Vector) for Aβ42 stain. Lower-power digitized images were acquired
with a BX-60 microscope (Olympus, Melville, NY) equipped with a
DEI-470 digital camera (Optronics, Goleta, CA).
2.15. Statistical analysis
Results are expressed as mean values and standard deviation of
results obtained from ﬁve separate experiments. Statistical analysis
was performed with one way ANOVA, followed by the Bonferroni test
using Sigma-stat 3.1 software (SPSS, Chicago, IL, USA). p-Values b0.05
and b0.01 were considered to be signiﬁcant.
3. Results
3.1. Characterization of SH-SY5Y, APPwt and APPmut cells
3.1.1. Oxidative stress
Several clones of cells overexpressing wild type or mutant
val717gly AβPP were developed. Cells were ﬁrst characterized for
AβPP overexpression. The two clones, stably transfected with either
APPwt or APPmut, expressed comparable AβPP levels, but higher than
those found in non-transfected cells (Fig. 1) and released signiﬁcantly
higher amounts of Aβ42 (data not shown), as previously demonstrated
by Zampagni et al. [32]. In detail, using the monoclonal antibody 6E10
that recognizes an epitope corresponding to the aa 1–17 inside the frag-
ment Aβ42 of the AβPP, we identiﬁed two bands, speciﬁcally the full
length at 130 kDa and an isoform at 110 kDa (Fig. 1). It is in fact well
demonstrated that AβPP exists in different isoforms and that its prod-
ucts can be also identiﬁed by western blotting analysis [33–37].
The two clones were compared in terms of redox proﬁle by evaluat-
ing the levels of different oxidativemarkers, which are the ﬁnal products
of oxidation and nitrosylation processes. In particular, we focused on
protein-bound HNE, which is one of themain products of lipid peroxida-
tion [38], and on 3-NT and PC, established indicators of ROS-mediated
protein oxidation [25,39,40]. Results are summarized in Table 1.
Protein-bound HNE, 3-NT and PC levels were signiﬁcantly higher in
APPmut in comparison to APPwt cells. Moreover, all the three oxidative
markers in APPwt were at least 2-folds higher that those found in
SH-SY5Y non-transfected cells. As an additional index of cell redox state,
we evaluated basal mitochondrial ROS levels using a confocal microscopy
in living cells after exposure to the lowest laser light intensity (5%). Levels
of mitochondrial ROS generated in APPmut were at least 3-folds higher
compared to non-transfected cells. Surprisingly, APPwt mitochondria
produced a very low amount of ROS in comparison with both APPmut
and SH-SY5Y untransfected cells.
3.1.2. UPS and autophagy
Proteasomal and lysosomal activities weremeasured in the three cell
lines as described in theMaterial andmethods 2.11 and 2.12 sections and
data are illustrated in Fig. 2. A different and subunit-dependent pattern ofproteasome inhibition was observed in the two transfected cell lines
(panel A). In details, in APPmut cells, except for the BrAAP, all the
proteasomal components were severely compromised, whereas only
the ChT-L activitywas slightly reduced in APPwt cells.With respect to ly-
sosomal proteolysis, both cathepsin B and L activities were markedly
up-regulated in APPmut cells, whereas no differences were detected in
APPwt cells compared to untransfected cells (panel B). Then, we moni-
tored the state of the autophagic ﬂux by stimulating autophagy through
serum deprivation. Immunoﬂuorescence analysis was performed to in-
vestigate the intracellular localization of the autophagosome membrane
protein LC3. Two forms of LC3, namely LC3-I (cytosolic) and LC3-II
(membrane-bound), were produced post-translationally in various cells.
During the activation of autophagy, LC3-I is processed and recruited to
autophagosome, where LC3-II is generated by site-speciﬁc proteolysis
and lipidation near the C-terminus. Fig. 3 shows the immunoﬂuorescence
analysis carried out with an anti-LC3 antibody, which recognizes the two
isoforms. In SH-SY5Y untransfected cells, LC3 immunostaining was
diffuse, indicative of the more abundant cytoplasmic isoform LC3-I.
When cells were starved, LC3 peculiar punctuate stainingwas observed,
pinpointing the autophagosome formation. Interestingly, SH-SY5Y cells
stably transfected with wild-type APP yet in basal condition expressed
the LC3 punctuate staining, suggesting an autophagic process in place.
After 8 h of starvation, cells appeared similar to the basal condition con-
trol, suggesting that the serumdeprivation stimulus did not activate the
autophagy process in APPwt clone. Also in APPmut cells after the starva-
tion stimulus, only very limited LC3 immunopositive dots were observed,
but, different from the wild type counterpart, cells overexpressing AβPP
mutant in basal condition showed a diffuse staining with anti-LC3 anti-
body (Fig. 3, panel A).
The levels of the autophagy related proteins LC3-II, beclin-1 and p62
and of Ub–protein conjugates were detected through western blotting
assays. While beclin-1 plays a key role in autophagy being involved in
Fig. 2. Basal activity of the UPS and cathepsins in SH-SY5Y, APPwt and APPmut cells.
Cells were investigated for the basal activity of both the UPS (panel A) and cathepsins
(panel B). Results are presented as ﬂuorescence units. Data points marked with an asterisk
are statistically signiﬁcant compared to control SH-SY5Y cells (*pb0.05, **pb0.01).
Fig. 3. Detection of autophagy-related proteins. Panel A. LC3 ﬂuorescent identiﬁcation and
deprivation. *pb0.0001 SH-SY5Y at 6 h and SH-SY5Y at 8 h vs SH-SY5Y cont, §pb0.0001 A
starved for 8 h and cell viability was determined with the MTT assay (panel B). Lysates we
conjugates. Panels C and D show respectively representative immunoblots and densitometri
by using an anti-GAPDH antibody. The detection was executed by an ECL western blotting an
to their respective non treated control cells (*pb0.05, **pb0.01). (A.U.) arbitrary units.
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both LC3-II and ubiquitin, and isﬁnally degraded in autophagolysosomes
[41,42]. Therefore, its levels inversely correlate with the autophagic ac-
tivity. Data are illustrated in Fig. 3 (panels C and D). In accordance with
the immunoﬂuorescence data, serum starved APPmut cells displayed a
defect in the autophagosome formation process, showing lower levels
of both LC3-II and beclin-1 compared to control SH-SY5Y cells. Converse-
ly, the amount of both proteins did not change in APPwt cells, conﬁrming
the absence of autophagy activation upon the starvation stimulus. As for
p62, in linewith previous data demonstrating signiﬁcantly lower p62 cy-
tosolic levels in the frontal cortex of AD patients compared to control
subjects [43], we observed lower basal amounts in APPmut cells com-
pared to untransfected SH-SY5Y cells. When cells were starved, in both
cell lines a decrease in p62 levels was detected, indicative of no changes
at this phase of the autophagic cascade. Finally, serum deprivation pro-
moted the accumulation of Ub–protein conjugates, most likely in re-
sponse to the production of ROS associated to the serum deﬁciency
[44,45].
In this scenario, with the overexpression of the amyloid precursor
protein determining an extensive re-modulation of the interplay be-
tween proteasome and autophagy in neurons, we tried to individuate
a possible intermediary in such reorganization focusing our attention
on the histone deacetylase 6 (HDAC6). Analyzing our models, we
obtained higher expression levels and an enhanced HDAC6 activity,
measured in terms of Hsp90-lysine acetylation, in APPmut cells
(Figs. 4–9), suggesting the cellular attempt to activate compensatory
autophagy in response to the severe proteasomal inhibition.Hoechst stain in SH-SY5Y, APPwt and APPmut cells in basal condition and upon serum
PPwt vs SH-SY5Y control, #pb0.0001 APPwt vs APPmut cells. Then, cells were serum
re analyzed for autophagy-related proteins (LC3-II, beclin-1 and p62) and Ub–protein
c analyses obtained from ﬁve separate experiments. Equal protein loading was veriﬁed
alysis system. Data points marked with an asterisk are statistically signiﬁcant compared
Fig. 4. Detection of HDAC6 levels. HDAC6 expression in control SH-SY5Y, APPwt and
APPmut cells. Panel A shows the densitometric analysis obtained from ﬁve separate
blots and panel B shows a representative immunoblot. Equal protein loading was veriﬁed
by using an anti-GAPDH antibody (panel C). The detectionwas executed by an ECLwestern
blotting analysis system. Data points marked with an asterisk are statistically signiﬁcant
compared to their respective non treated control cells (*pb0.05, **pb0.01). (A.U.) arbitrary
units.
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Upon 24 h of amyloid treatment, cells were assayed for the simul-
taneous detection of the 20S proteasome, the Aβ42 and the cathepsin
B. Pictures were obtained after trichrome staining with the three an-
tibodies. The proteasome is colored in black, the Aβ42 in brown and the
cathepsin B in purple (Fig. 5). SH-SY5Y cells showed an evident nuclear
expression of the 20S proteasome particularly marked upon oligomer
treatment. Furthermore, when cells were exposed to the soluble form
of the peptide we obtained the co-expression of the cathepsin B and
the 20S core, with higher levels of the lysosomal enzyme with respect
to the proteasome. High expression levels of the 20S proteasome wereFig. 5. 20S proteasome, Aβ42 and cathepsin B cellular localization. Upon 24 h of exposure to
cells were analyzed for the localization of cathepsin B (violet), Aβ42 (brown) and 20S coredetected in the APPwt cells exposed to amyloid oligomers. APPmut cells
displayed a very singular pattern. When these cells were treated with
the soluble form of the peptide, they displayed a marked expression of
the cathepsin B with almost no signal for the 20S proteasome. The detec-
tion of the 20S core was more evident upon treatment with oligomers.
Interestingly, both APPwt and APPmut clones displayed an evident ca-
thepsin B nuclear expression, indicating the contribution of the enzyme
to nuclear alterations occurring in AD.
3.3. Proteasome activities in amyloid treated cells
Cells were treated with 1 μM of Aβ42 in its soluble and oligomeric
forms. No signiﬁcant change in cell survival was observed, just a 15%
decrease after 24 h of treatment with amyloid oligomeric species. Fur-
thermore, the three cell lines did not show morphological differences
in response to the treatment (data not shown). Following amyloid ex-
posure, proteasome activities on cell lysates weremeasured. Results re-
lated to the four 20S proteasome components and to the ChT-L activity
of the 26S proteasome are illustrated in Fig. 6. Data indicate a signiﬁcant
inhibition of the enzymatic complex with a marked decrease of all the
tested activities, particularly evident upon 24 h of treatment and in
the presence of Aβ42 oligomers. APPmut cellswere themost susceptible
to the treatment. Western blotting assays with anti-20S proteasome
antibodies did not show any changes in 20S core expression upon
amyloid treatment, demonstrating that the decrease in proteasome
functionality was effectively related to a reduced activity rather than to
a lower expression of its subunits (data not shown). Such data were
also conﬁrmed by the accumulation of Ub-conjugates, known markers
of proteasome inhibition, mainly in response to a 24 h treatment with
oligomeric structures (Fig. 7).
3.4. Cathepsins activities in amyloid treated cells
Cathepsins are proteolytic enzymes responsible for the endosomal–
lysosomal degradation.Wemonitored the lysosomal functionalitymea-
suring the activity of cathepsins B and L that were demonstrated to play1 μM Aβ42 soluble (S) and oligomeric forms (O), control SH-SY5Y, APPwt and APPmut
(black). (C): non treated control cells. Scale bar 50 μm.
Fig. 6. Effect of Aβ42 treatment on UPS activity. Proteasome activities were measured in cell lysates upon 6 and 24 h of exposure to 1 μM of soluble and oligomeric forms of Aβ42 as
described in the Material and methods 2.11 section. (C) Control, (S) Aβ42 soluble forms and (O) Aβ42 oligomers. Results are presented as percentage of activity remaining toward
control in each time set. Fluorescence units were subtracted of the values of control assays in the presence of speciﬁc inhibitors. Data points marked with an asterisk are statistically
signiﬁcant compared to their respective non treated control cells (*pb0.05, **pb0.01).
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APPmut cell line showed an impaired enzymatic activity. Interestingly,
the inhibition was already evident upon short exposure time (6 h)
(Fig. 8). Western blotting assays using anti-cathepsin B and anti-
cathepsin L antibodies conﬁrmed that such inhibition was not the
consequence of a decreased expression of the cathepsins (data not
shown).3.5. Expression of HDAC6 and Hsp90 acetylation in amyloid treated cells
HDAC6 is considered an important link betweenUPS and autophagy.
Previously, we indicated that APPmut cells were characterized by high
levels of HDAC6 and by a parallel decrease of the Hsp90 acetylated ly-
sine content. Upon cell treatment with the amyloid peptide increased
levels of this deacetylase were detected (Fig. 9, left panel). Such ampli-
ﬁed expression was mainly evident in the APPmut cell line. In fact, the
exposure to oligomeric structures and to the soluble form of the proteincausedHDAC6 levels 1.54- and 1.17-fold higher, respectively, compared
to control untreated cells. To gain further insight into the regulation of
the intracellular proteolysis upon amyloid treatment, we measured
the activity of HDAC6 in terms of Hsp90 lysine acetylation (Fig. 9,
right panel). Consistent with the increased levels of HDAC6, the
immunoprecipitated Hsp90 showed a decrease in its extent of acetyla-
tion. In detail, considering the APPmut cell line, the treatment with the
soluble peptide andwith the oligomers caused a 1.82- and 2.20-fold de-
crease, respectively, compared to control APPmut untreated cells.4. Discussion
The UPS and autophagy have been thought as relatively distinct
systems sharing a common role and a common substrate: the proteoly-
sis of misfolded proteins. However, recent ﬁndings strongly suggest the
existence of a crosstalk and even a cooperation between these two deg-
radation pathways [46]. Both systems are involved in the onset of
Fig. 7. Effect of Aβ42 treatment on Ub–protein conjugates. Levels of Ub–protein conjugates
in SH-SY5Y, APPwt and APPmut cells treatedwith Aβ42 for 6 and 24 h. (C) Control, (S) Aβ42
soluble forms and (O) Aβ42 oligomers. Panel A shows the densitometric analysis obtained
from ﬁve separate blots and panel B shows a representative immunoblot. Equal protein
loading was veriﬁed by using an anti-GAPDH antibody (panel C). The detection was exe-
cuted by an ECLWestern Blotting analysis system. Data pointsmarkedwith an asterisk are
statistically signiﬁcant compared to their respective not treated control cells ( pb0.05,
**pb0.01). (A.U.) arbitrary units.
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ronal death mechanisms. In the present study, we analyzed the relation-
ship between the UPS and autophagy in a human cellular model of AD,
investigating how proteolysis was regulated in such a compromised con-
dition. Speciﬁcally, the study was carried out on SH-SY5Y neuroblas-
toma cells stably transfected with wild-type AβPP gene (APPwt) or
717 valine-to-glycine AβPP-mutated gene (APPmut). The two clonesFig. 8. Effect of Aβ42 treatment on cathepsin B and L activity. Activities of both cathepsin B
soluble and oligomeric forms of Aβ42 as described in the Material and Methods 2.11 section.
as percentage of activity remaining toward non treated control cells (A–C) and as ﬂuorescen
speciﬁc inhibitors. Data points marked with an asterisk are statistically signiﬁcant compareexpressed a comparable amount of AβPP protein, although the APPmut
clone produced and released signiﬁcantly higher amounts of Aβ42 as
previously described by Zampagni et al. [32]. The analysis of oxidative
markers, such as the HNEMichael adduct, 3-NT and PC levels, provided
evidence that AβPP over-expression and Aβ42 overload induced oxida-
tive stress and increased the vulnerability to oxidative stress, contribut-
ing signiﬁcantly to neuronal death in AD. Nevertheless, oxidativemarkers
were signiﬁcantly higher in APPmut cells than those found in the APPwt
clone, suggesting the direct correlation between Aβ42 levels and oxidative
stress, in agreement with previous studies [47,48]. Data onmitochondrial
ROS generation showed that differences between APPmut and APPwt
clones were not only in terms of oxidative stress amount, but probably
they developed a different strategy to compensate for the detrimental en-
vironment. In fact, it is noteworthy that the APPwt clone expressed very
low levels of ROS inside the mitochondria, whereas ROS production was
very high in APPmut cells. At this regard, Cenini et al. [49] demonstrated
in HEK293 cells stably transfected with APP751wt the presence of
adaptive responses, including an increased expression and activity
of Mn-superoxide dismutase, to counteract an increased oxidative
stress. However, in HEK-APP751 717 valine-to-glycinemutant clone, ox-
idative stress was so high that cells were not able to develop such strat-
egies. This behavior observed inHEKAPPwt aswell as in SH-SY5YAPPwt
is explained by the “hormesis theory” [50,51]. The fact that a strong in-
crease in oxidative stress and an impairedmitochondrial functionality al-
ways accompany AD makes them an appealing target for possible
therapeutic interventions. Besides the conventional antioxidant-based
therapies, alternative strategies, such as the possibility to potentiate cel-
lular stress responses through hormetic stimulation, are under investiga-
tion. At this regard, a promising target could be represented by vitagenes,
a class of sensitive and cytoprotective genes involved in preserving cel-
lular homeostasis during stressful conditions [52,53]. Among vitagene
products, molecules endowed with antioxidant and anti-apoptotic ac-
tivities (heat shock proteins Hsp32, Hsp70, glutathione, the thioredoxin
and the sirtuin protein systems) are included. This network acts in re-
sponse to age-associated mitochondrial dysfunctions and is modulatedand cathepsin L were measured in cell lysates upon 6 and 24 h of exposure to 1 μM of
(C) Control, (S) Aβ42 soluble forms and (O) Aβ42 oligomers. Results are presented both
ce units (B–D). Data were subtracted of the values of control assays in the presence of
d to their respective non treated control cells (*pb0.05, **pb0.01).
Fig. 9. Effect of Aβ42 treatment on HDAC6 levels and activity. Left box: HDAC6 levels in SH-SY5Y, APPwt and APPmut cells treated with Aβ42 for 24 h. Panel A shows the densito-
metric analysis obtained from ﬁve separate blots and panel B shows a representative western blotting. Equal protein loading was veriﬁed by using an anti-GAPDH antibody (panel
C). Right box: HDAC6 activity was measured in terms of Hsp90 acetylation. SH-SY5Y, APPwt and APPmut cells were treated with Aβ42 for 24 h. Cell lysates were then
immunoprecipitated with an anti-Hsp90 antibody followed by immunoblotting with an anti-Ack antibody. Panel A shows the densitometric analysis obtained from ﬁve separate
blots and panel B shows a representative immunoblot. The equal amount of immunoprecipitated Hsp90 was veriﬁed using anti-Hsp90 antibody (panel C). (C): Control, (S): Aβ42 soluble
forms, (O): Aβ42 oligomers. The detection was executed by an ECL analysis system. Data points marked with an asterisk are statistically signiﬁcant compared to their respective non treated
control cells (*pb0.05, **pb0.01). (A.U.) arbitrary units.
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deeper understanding of the relationship between the vitagene network
and the hormetic dose response mechanisms may support the stimula-
tion of maintenance and repair pathways through exogenous interven-
tions, such as mild stress or nutritional antioxidants targeting the
vitagene network, as a novel approach for those pathophysiological
conditions, including neurodegenerative disorders [53–55].
The elevated levels of Aβ42 and the increased oxidative damage
observed in APPmut cells determined a signiﬁcantly altered proteo-
lytic pattern with the inhibition of the proteasome functionality and
the deregulation of the autophagic pathway. This latter was con-
ﬁrmed by the increase in cathepsins activity and by the parallel de-
fects in autophagosome formation. Additionally, both clones displayed a
marked nuclear staining of cathepsin B, suggesting that lysosomal en-
zymes participate to the nuclear alterations occurring in AD [56]. Previ-
ous data reported on the ability of the cytoplasmic enzyme HDAC6 to
mediate the compensatory activation of autophagy in D. melanogaster
models of spinobulbar muscular atrophy [15,19]. Based on these obser-
vations, we focused our attention on this deacetylase as a possible inter-
mediary of the observed proteolysis re-modulation. Interestingly, our
results showed that APPmut cells displayed higher expression levels
and an enhanced activity of HDAC6, supporting the hypothesis that in
AD pathogenesis cells try to remedy to proteasomal inhibition by acti-
vating HDAC6-dependent autophagy.
A similar approach to clarify the molecular mechanism underlying
Aβ neurotoxicity was followed by Matsumoto et al. who found in
SH-SY5Y cells overexpressing AβPP a reduced proteasomal activity asso-
ciated to increased susceptibility to oxidative stress. However, in this
work such alterations were observed upon the APPwt overexpression
whereas the expression of APPmut (His684Arg mutation) increased
Aβ42 excretion, but did not affect cell properties [57].
Cells were then treated with Aβ42, the most toxic amyloid beta form,
to better elucidate its contribution to the different phenotypes observed
in ourmodels.We already demonstrated that SH-SY5Y cells treatedwith
amyloid oligomers showed a compromised proteasome activity [28]. In
the present work we provided evidence that, upon amyloid treatment,
the proteasomal functionality resulted clearly impaired not only in
APPmut cells but also in APPwt clones and control SH-SY5Y cells,
suggesting the existence of a critical Aβ42 threshold beyond which the
proteasomal machinery becomes dysfunctional. Such alterations were
considerably visible after exposure to Aβ42 oligomers and matched
with the accumulation of Ub-conjugates. In addition, the nuclear redistri-
bution and accumulation of 20S proteasome upon oligomer exposuresuggested that the proteasome takes part in DNA repair and/or cell
death mechanisms occurring in AD.
Upon amyloid treatment, the previously reported upregulation of
HDAC6 was now evident in all the analyzed models, both in terms of
expression and activity, indicative of the cellular attempt to trigger
the autophagic pathway in response to oligomer-associated proteasome
impairment. Interestingly, the increased HDAC6 activity induced an al-
most complete deacetylation of its substrate Hsp90, which in the
hypoacetylated form is able to carry out its normal role.
Control SH-SY5Y and APPwt cells did not show alterations in ca-
thepsins B and L activities in response to the amyloid treatment
whereas inhibited functionalities were observed in APPmut clones.
Aβ42 aggregates were demonstrated to induce pro-oxidative effects
to the lysosomal membrane in SH-SY5Y cells with the loss of imper-
meability and leakage of lysosomal hydrolases into the cytosol [58,59].
Here we propose that the increase in Aβ42 content and elevated levels
of oxidative damage in APPmut cells contribute to lysosomal membrane
alterations. As neurons become more compromised by the excess in am-
yloid content, the initial lysosomal system up-regulation observed in
non-treated APPmut cells is replaced by lysosomal dysfunctions. In
addition, previous studies illustrated that Aβ42 is selectively uptaken
by neurons and that the peptide is extremely resistant to degradation,
favoring the accumulation of the protein and the increase of
C-terminal APP fragments, which in turn further promote the produc-
tion of Aβ42 [60,61]. According to these data, it is reasonable to hypoth-
esize that in our models the internalized amyloid stimulates such
mechanisms and contributes to the generation of new toxic amyloid
species. Finally, the amyloid peptide overload induces the dramatic in-
hibition of both the proteasome and cathepsins activities, leading to
neuronal degeneration.
Concluding, our ﬁndings indicate that the excessive release of Aβ42
promotes a remarkable reorganization of the crosstalk between UPS and
autophagy and demonstrate the existence of an amyloid threshold be-
yondwhich cellular proteolysis becomes deﬁnitely dysfunctional. How-
ever, more efforts are needed to explore the functional relationship
between the UPS and autophagy and to widen our knowledge of the
mechanisms through which misfolded proteins are oriented toward
one proteolytic system or the other.
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